India Resurgence Fund (India RF), a joint venture between Bain Capital Credit and Piramal Enterprises to invest in distressed assets in India, has agreed to invest up to INR9.9 billion ($144 million) in Indian pharmaceutical developer Panacea Biotec.
India RF will invest primarily through non-convertible debentures valued at up to INR8.6 billion. It will also subscribe to share warrants worth INR320 million, with the option to expand its equity investment...
Temasek Holdings, Cathay Capital Private Equity, and Haochen Capital have led a $55 million Series B round for WeNext Technology, a China-based 3D printing specialist.
SoftBank Vision Fund 2 has made a Series D investment of undisclosed size in Japan’s Soda, operator of sneaker reselling platform Snkr Dunk, at a valuation of JPY38 billion ($336 million).
Singapore’s LingoAce, a Chinese language learning app, has raised $105 million in Series C funding led by Sequoia Capital India. It comes within a year of a $55 million Series B.
CVC Capital Partners is supporting a proposed founder-led privatization of Hong Kong-listed gaming hardware and software provider Razer that values the business at HK$24.7 billion ($3.17 billion).